Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals

Information

  • Patent Application
  • 20240309417
  • Publication Number
    20240309417
  • Date Filed
    January 16, 2024
    10 months ago
  • Date Published
    September 19, 2024
    2 months ago
Abstract
An engineered microorganism(s) with novel pathways for the conversion of short-chain hydrocarbons to fuels and chemicals (e.g. carboxylic acids, alcohols, hydrocarbons, and their alpha-, beta-, and omega-functionalized derivatives) is described. Key to this approach is the use of hydrocarbon activation enzymes able to overcome the high stability and low reactivity of hydrocarbon compounds through the cleavage of an inert C—H bond. Oxygen-dependent or oxygen-independent activation enzymes can be exploited for this purpose, which when combined with appropriate pathways for the conversion of activated hydrocarbons to key metabolic intermediates, enables the generation of product precursors that can subsequently be converted to desired compounds through established pathways. These novel engineered microorganism(s) provide a route for the production of fuels and chemicals from short chain hydrocarbons such as methane, ethane, propane, butane, and pentane.
Description
FEDERALLY SPONSORED RESEARCH STATEMENT

Not applicable.


FIELD OF THE DISCLOSURE

The disclosure generally relates to the use of microorganisms with novel pathways for the conversion of short-chain hydrocarbons (e.g. methane, ethane, propane, butane, pentane) to fuels and chemicals (e.g. carboxylic acids, alcohols, hydrocarbons, and their alpha-, beta-, and omega-functionalized derivatives).


BACKGROUND OF THE DISCLOSURE

Global natural gas (CH4) resources that are technically recoverable with new horizontal drilling and efficient extraction technologies are estimated at 7.2×103 trillion cubic feet (Tcf), with estimates for the US ranging between 0.65×103 Tcf and up to 2×103 Tcf. Furthermore, about 5 trillion cubic feet (Tcf) of natural gas liquids or NGLs (primarily ethane, propane and butane) are produced annually in the United States and technically recoverable reserves of this resource are estimated at over 400 Tcf based on wet natural gas estimates.


The invention re-purposes native pathways for anaerobic and aerobic activation of medium- and long-chain hydrocarbons (C6-C20) to function with short-chain substrates (C1-C5). Through these engineered pathways, the short-chain hydrocarbon substrates are converted to central, intracellular metabolites such as acetyl-CoA, which can in turn be converted to a variety of fuels and chemicals through other native or engineered pathways.


SUMMARY OF THE DISCLOSURE


This invention demonstrates pathways that can be utilized for the conversion of short chain hydrocarbon feedstocks to a variety of fuels and chemicals. This is accomplished through key pathway modules for hydrocarbon activation and conversion to an acyl-CoA intermediate, generation of product precursor acetyl-CoA, which in certain cases also entails the generation of an addition acyl-CoA or keto-acid, and the formation of a desired product from acetyl-CoA. Dependent on the type of hydrocarbon activation pathway utilized, the regeneration of compounds required for activation from an acyl-CoA or keto-acid intermediate are also required.


Two main approaches for short chain hydrocarbon activation are exploited: 1) the oxygen-independent activation via fumarate addition, which given the need for fumarate during oxygen-independent activation also requires pathways for the regeneration of this intermediate for continued activation cycles, and 2) the oxygen-dependent activation via the terminal addition of a hydroxyl group to the alkane.


As used herein, an “oxygen-independent activation via fumarate addition” is the addition of fumarate to an alkane leading a 2-methyl-alkyl-succinate:




embedded image


The enzyme that catalyzes this reaction is an “alkyl succinate synthase,” and more than 40 such examples are exemplified herein. Alkyl succinate synthases that are specific for methane as a substrate are called “methyl succinate synthases,” for ethane they are called “ethyl succinate synthases,” and so on, although there are of course enzymes with broader substrate specificity.


As used herein, an “oxygen-dependent activation” is the terminal addition of a hydroxyl group to the alkane to form a primary alcohol.




embedded image


The enzyme that catalyzes this reaction is an “alkane monooxygenase” or “alkane hydroxylase”, and as above, they may sometimes be named according the alkane substrate specificity, although there are of course enzymes in both classes with broader substrate specificity. Several examples are provided herein.


Regardless of the activation pathway utilized, the resulting activated compound is then converted into an acyl-CoA intermediate through a series of reactions. Once the given acyl-CoA intermediate is produced, various pathways dependent on the type of acyl-CoA generated can be exploited for the generation of the product precursor acetyl-CoA.


Synthesis of the desired product(s) from acetyl-CoA can be accomplished through various engineered metabolic pathways, including a reversal of the beta-oxidation cycle (BOX-R) or the fatty acid biosynthesis (FAS) pathway. Following chain elongation through either of these pathways, the selection of a given termination pathway enables the synthesis of various product families.


As used herein “termination pathway” or “termination enzyme(s)” refers to one or more enzymes (or genes encoding same) that will pull reaction intermediates out the BOX-R or FAS cycle and produce the desired end product.


By “primary termination pathway” what is meant is an intermediate from the BOX-R or FAS cycle is pulled out of the BOX-R or FAS cycle by one (which can have more than one activity) or more termination enzymes and results in i) carboxylic acids, ii) primary alcohols, iii) hydrocarbons, or iv) primary amines, from CoA intermediates as described in FIG. 1.


By “secondary termination pathway” what is meant is that the intermediate pulled out of the BOX-R or FAS cycle by a primary termination pathway enzyme is further modified by one or more enzymes.


Many examples of termination pathways are available and the following table provides several examples:









TABLE A







Termination Pathways for Conversion of CoA Intermediates to Desired Products

















Protein Accession


Reaction
Illustration
EC
Enzyme names
Source organism and gene name
Numbers















Acyl-CoA→ Carboxylic acid


embedded image


3.1.2.-            
Thioesterase            

E. coli tesA E. coli tesB E. coli yciA E. coli fadM E. coli ydil E. coli ybgC Alcanivorax borkumensis tesB2

NP_415027.1 NP_414986.1 NP_415769.1 NP_414977.1 NP_416201.1 NP_415264.1 YP_692749.1







Fibrobacter succinogenes Fs2108

YP_005822012.1







Prevotella rumincola Pr655

YP_003574018.1







Prevotella ruminicola Pr1687

YP_003574982.1




2.8.3.8
Acyl-CoA:acetyl-

E. coli atoD

NP_416725.1





CoA transferese

Clostridium kluyveri cat2

AAA92344.1







Clostridium acebotuylicum

NP_149326.1






ctfAB
NP_149327.1







E. coli ydiF

NP_416209.1




2,3,1,-;
Phosphotrans-

Clostridium acetobutylicum ptb

NP_349676.1




2.7.2.1;
acylase +

Enterococcus faecalis ptb

AAD55374.1




2.7.2.15
Carboxylate

Salmonella enterica pduL

AAD39011.1





kinase

Clostridium acetobutylicum buk

AAK81015.1







Enterococcus faecalis buk

AAD55375.1







Salmonella enterica pduW

AAD39021.1





Acyl-CoA→ Alcohol


embedded image


1.2.1.84
Alcohol-forming CoA reductase

Clostridium acetobutylicum adhE2 Arabidopsis thaliana At3g11980 Arabidopsis thaliana At3g44560 Arabidopsis thaliana At3g56700 Arabidopsis thaliana At5g22500 Arabidopsis thaliana CER4

YP_009076789.1 AEE75132.1 AEE77915.1 AEE79553.1 AED93034.1 AEE86278.1







Marinobacter aquaeolei VTB

YP_959486.1






maqu_2220








Marinobacter aquaeolei VTB

YP_959769.1






maqu_2507






Acyl-CoA→ Aldehyde


embedded image


1.2.1.10
Aldehyde forming CoA reductase

Acinetobacter calcoaceticus acr1 Acinetobacter sp Strain M-1 acrM Clostridium beijerinckii ald E. coli eut E Salmonella enterica eutE E. coli mhpF

AAC45217.1 BAB85476.1 AAT66436.1 NP_416950.1 AAA80209.1 NP_414885.1





Aldehyde→ Alcohol


embedded image


1.1.1.-
Alcohol dehydrogenase

E. coli betA E. coli dkgA E. coli eutG E. coli fucO E. coli upcA E. coli yahK E. coli ybbO

NP_414845.1 NP_417485.4 NP_416948.4 NP_417279.2 NP_416921.1 NP_414859.1 NP_415026.1







E. coli ybdH

NP_415132.1







E. coli yiaY

YP_026233.1







E. coli yjgB

NP_418690.4





Aldehyde→ Alkane


embedded image


4.1.99.5
Aldehyde decarbonylase

Synechococcus elongatus PCC7942 orf1593 Nostoc punctiforme PCC73102 npun_R1711 Prochlorococcus marinus MIT9313 pmt1231

Q54764.1   B2J1M1.1   Q7V6D4.1  





Aldehyde→ Amine


embedded image


2.6.1.-
Transaminase

Arabidopsis thaliana At3g22200 Alcalgenes denitrificans AptA Bordetella bronchiseptica BB0869 Bordetella parapertussis BPP0784 Brucella melitensis BAWG_0478 Burkholderia pseudomallei BP1026B_I0669

NP_001189947.1 AAP92672.1 WP_015041039.1 WP_010927683.1 EEW88370.1 AFI65333.1  







Chromobacterium violaceum

AAQ59697.1






CV2025








Oceanicola granulosus

WP_007254984.1






OG2516_07293








Paracoccus denitrificans PD1222

ABL72050.1






Pden_3984








Pseudogulbenkiania ferrooxidans

WP_008952788.1






ω-TA








Pseudomonas putida ω-TA

P28269.1







Ralstonia solanacearum ω-TA

YP_002258353.1







Rhizobium meliloti SMc01534

NP_386510.1







Vibrio fluvialis ω-TA

AEA39183.1







Mus musculus abaT

AAH58521.1







E. coli gabT

YP_490877.1





Carboxylic Acid→ ω-hydroxy- acid


embedded image


1.14.-
Carboxylic acid omega hydroxylase

Pseudomonas putida alkBGT     Marinobacter aquaeolei CYP153A Mycobacterium marinum CYP153A16 Polaromonas sp. CYP153A Nicotiana tabacum CYP94A5 Vicia sativa CYP94A1 Vicia sativa CYP94A2 Arabidopsis thaliana CYP94B1 Arabidopsis thaliana CYP86A8 Candida tropicalis CYP52A1

YP_009076004.1, Q9WWW4.1, Q9L4M8.1 ABM17701.1 YP_001851443.1   YP_548418.1 AAL54887.1 AAD10204.1 AAG33645.1 BAB08810.1 CAC67445.1 AAA63568.1,










AAA34354.1,







AAA34334.1







Candida tropicalis CYP52A2

AAA34353.2,







CAA35593.1







Homo sapiens CYP4A11

AAQ56847.1





ω-hydroxy- acid→ ω-oxo-acid


embedded image


1.1.1.-
Alcohol oxidase/ alcohol dehy- drogenase

Rhodococcus ruber SC1 cddC Acinetobacter sp. SE19 chnD E. coli yah K E. coli yjgB

AAL14237.1 AAG10028.1 NP_414859.1 NP_418690.4





ω-oso-acid→ dicarboxylic acid


embedded image


1.2.1.-
Aldehyde dehydrogenase

Rhodococcus ruber SC1 cddD Acinetobacter sp SE19 chnE

AAL14238.1 AAG10022.1





Carboxylic Acid→ α- hydroxyacid


embedded image


1.14.-
Carboxylic acid alpha hydroxy- lase

Myxococcus xanthus MXAN_0191 Stigmatella aurantiaca STIAU_3334

YP_628473.1 YP_003957653.1









The synthetic pathway disclosed in this invention serves as a platform for the generation of valuable chemical products from less valuable and more abundant hydrocarbon feedstocks. Methane, for example, can be converted into liquid “drop in” fuels for use in the current transportation infrastructure. The methods, materials and systems herein thus allow for various chain length hydrocarbons to be activated and assimilated into central carbon metabolism allowing for product synthesis via numerous native and synthetic pathways.


The process involves performing traditional cultures using industrial organisms (such as E. coli, S. cerevisiae, Methylococcus capsulatus, or Pichia pastoris) that convert short-chain hydrocarbons (such as methane, ethane, propane, butane, or pentane) into chemical products. These organisms are considered workhorses of modern biotechnology, and are easy to genetically engineer, and scale up for industrial production levels of desired products.


The pathways in a living system are generally made by transforming the microbe with an expression vector encoding one or more of the proteins, but the genes can also be added to the chromosome by recombineering, homologous recombination, and similar techniques. Where the needed protein is endogenous, as is the case in some instances, it may suffice as is, but it is usually overexpressed using an inducible promoter for better functionality and user-control over the level of active enzyme.


As used herein, the expressions “microorganism,” “microbe,” “strain” and the like may be used interchangeably and all such designations include their progeny. It is also understood that all progeny may not be precisely identical in DNA content, due to deliberate or inadvertent mutations. Mutant progeny that have the same function or biological activity as screened for in the originally transformed cell are included. Where distinct designations are intended, it will be clear from the context.


As used herein, reference to a “cell” is generally understood to include a culture of such cells, as the work described herein is done in cultures having 109-15 cells.


As used herein, “growing” cells used it its art accepted manner, referring to exponential growth of a culture of cells, not the few cells that may not have completed their cell cycle at stationary phase or have not yet died in the death phase or after harvesting.


As used in the claims, “homolog” means an enzyme with at least 50% identity to one of the listed sequences and also having the same general catalytic activity. While higher identity (60%, 70%, 80%) and the like may be preferred, it is typical for bacterial sequences to diverge significantly (40-60%), yet still be identifiable as homologs, while mammalian species tend to diverge less (80-90%).


Reference to proteins herein can be understood to include reference to the gene encoding such protein. Thus, a claimed “permease” protein can include the related gene encoding that permease. However, it is preferred herein to refer to the protein by standard name per ecoliwiki or HUGO since both enzymatic and gene names have varied widely, especially in the prokaryotic arts.


Once an exemplary protein is obtained, many additional examples of proteins with similar activity can be identified by BLAST search. Further, every protein record is linked to a gene record, making it easy to design overexpression vectors. Many of the needed enzymes are already available in vectors, and can often be obtained from cell depositories or from the researchers who cloned them. But, if necessary, new clones can be prepared based on available sequence information using RT-PCR techniques. Thus, it should be easily possible to obtain all of the needed enzymes for overexpression.


Another way of finding suitable enzymes/proteins for use in the invention is to consider other enzymes with the same EC number, since these numbers are assigned based on the reactions performed by a given enzyme. An enzyme that thus be obtained, e.g., from AddGene or from the author of the work describing that enzyme, and tested for functionality as described herein. In addition, many sites provide lists of proteins that all catalyze the same reaction.


Understanding the inherent degeneracy of the genetic code allows one of ordinary skill in the art to design multiple nucleotides that encode the same amino acid sequence. NCBI™ provides codon usage databases for optimizing DNA sequences for protein expression in various species. Using such databases, a gene or cDNA may be “optimized” for expression in E. coli, yeast, algae or other species using the codon bias for the species in which the gene will be expressed.


Initial cloning experiments have proceeded in E. coli for convenience since most of the required genes are already available in plasmids suitable for bacterial expression, but the addition of genes to bacteria is of nearly universal applicability. Indeed, since recombinant methods were invented in the 70's and are now so commonplace, even school children perform genetic engineering experiments using bacteria. Such species include e.g., Bacillus, Streptomyces, Azotobacter, Trichoderma, Rhizobium, Pseudomonas, Micrococcus, Nitrobacter, Proteus, Lactobacillus, Pediococcus, Lactococcus, Salmonella, Streptococcus, Paracoccus, Methanosarcina, and Methylococcus, or any of the completely sequenced bacterial species. Indeed, hundreds of bacterial genomes have been completely sequenced, and this information greatly simplifies both the generation of vectors encoding the needed genes, as well as the planning of a recombinant engineering protocol. Such species are listed along with links at en.wikipedia.org/wiki/List_of_sequenced_bacterial genomes.


Additionally, yeast, such as Saccharomyces, are a common species used for microbial manufacturing, and many species can be successfully transformed. Indeed, yeast are already available that express recombinant thioesterases—one of the termination enzymes described herein—and the reverse beta oxidation pathway has also been achieved in yeast. Other species include but are not limited to Candida, Aspergillus, Arxula adeninivorans, Candida boidinii, Hansemula polymorpha (Pichia angusta), Kluyveromyces lactis, Pichia pastoris, and Yarrowia lipolytica, to name a few.


It is also possible to genetically modify many species of algae, including e.g., Spirulina, Apergillus, Chlamydomonas, Laminaria japonica, Undaria pinnatifida, Porphyra, Eucheuma, Kappaphycus, Gracilaria, Monostroma, Enteromorpha, Arthrospira, Chlorella, Dunaliella, Aphanizomenon, Isochrysis, Pavlova, Phaeodactylum, Ulkenia, Haematococcus, Chaetoceros, Nannochloropsis, Skeletonema, Thalassiosira, and Laminaria japonica, and the like. Indeed, the microalga Pavlova lutheri is already being used as a source of economically valuable docosahexaenoic (DHA) and eicosapentaenoic acids (EPA), and Crypthecodinium cohnii is the heterotrophic algal species that is currently used to produce the DHA used in many infant formulas.


Furthermore, a number of databases include vector information and/or a repository of vectors and can be used to choose vectors suitable for the chosen host species. See e.g., AddGene.org which provides both a repository and a searchable database allowing vectors to be easily located and obtained from colleagues. See also Plasmid Information Database (PlasmID) and DNASU having over 191,000 plasmids. A collection of cloning vectors of E. coli is also kept at the National Institute of Genetics as a resource for the biological research community. Furthermore, vectors (including particular ORFS therein) are usually available from colleagues.


The enzymes can be added to the genome or via expression vectors, as desired. Preferably, multiple enzymes are expressed in one vector or multiple enzymes can be combined into one operon by adding the needed signals between coding regions. Further improvements can be had by overexpressing one or more, or even all of the enzymes, e.g., by adding extra copies to the cell via plasmid or other vector. Initial experiments may employ expression plasmids hosting 3 or more ORFs for convenience, but it may be preferred to insert operons or individual genes into the genome for long term stability.


Still further improvements in yield can be had by reducing competing pathways, such as those pathways for making e.g., acetate, formate, ethanol, and lactate, and it is already well known in the art how to reduce or knockout these pathways. See e.g., the Rice patent portfolio by Ka-Yiu San and George Bennett (U.S. Pat. Nos. 7,569,380, 7,262,046, 8,962,272, 8,795,991) and patents by these inventors (U.S. Pat. Nos. 8,129,157 and 8,691,552) (each incorporated by reference herein in its entirety for all purposes). Many others have worked in this area as well.


In calculating “% identity” the unaligned terminal portions of the query sequence are not included in the calculation. The identity is calculated over the entire length of the reference sequence, thus short local alignments with a query sequence are not relevant (e.g., % identity=number of aligned residues in the query sequence/length of reference sequence). Alignments are performed using BLAST homology alignment as described by Tatusova T A & Madden T L (1999) FEMS Microbiol. Lett. 174:247-250, and available through the NCBI website. The default parameters were used, except the filters were turned OFF.


“Operably associated” or “operably linked”, as used herein, refer to functionally coupled nucleic acid or amino acid sequences.


“Recombinant” is relating to, derived from, or containing genetically engineered material. In other words, the genetics of an organism was intentionally manipulated in some way.


“Reduced activity” is defined herein to be at least a 75% reduction in protein activity, as compared with an appropriate control species (e.g., the wild type gene in the same host species). Preferably, at least 80, 85, 90, 95% reduction in activity is attained, and in the most preferred embodiment, the activity is eliminated (100%). Proteins can be inactivated with inhibitors, by mutation, or by suppression of expression or translation, by knock-out, by adding stop codons, by frame shift mutation, and the like. All reduced activity genes or proteins are signified herein by “−”.


By “null” or “knockout” what is meant is that the mutation produces undetectable active protein. A gene can be completely (100%) reduced by knockout or removal of part of all of the gene sequence. Use of a frame shift mutation, early stop codon, point mutations of critical residues, or deletions or insertions, and the like, can also completely inactivate (100%) gene product by completely preventing transcription and/or translation of active protein. All null mutants herein are signified by A.


“Overexpression” or “overexpressed” is defined herein to be at least 150% of protein activity as compared with an appropriate control species, or any expression in a species that lacks the activity altogether. Preferably, the activity is increased 100-500% or even ten fold. Overexpression can be achieved by mutating the protein to produce a more active form or a form that is resistant to inhibition, by removing inhibitors, or adding activators, and the like. Overexpression can also be achieved by removing repressors, adding multiple copies of the gene to the cell, or up-regulating the endogenous gene, and the like. All overexpressed genes or proteins are signified herein by “+”.


In certain species it is possible to genetically engineer the endogenous protein to be overexpressed by changing the regulatory sequences or removing repressors. However, overexpressing the gene by inclusion on selectable plasmids or other vectors that exist in hundreds of copies in the cell may be preferred due to its simplicity and ease of exerting externals controls, although permanent modifications to the genome may be preferred in the long term for stability reasons.


The terms “operably associated” or “operably linked,” as used herein, refer to functionally coupled nucleic acid sequences.


As used herein “recombinant” is relating to, derived from, or containing genetically engineered material. In other words, the genome was intentionally manipulated by the hand of man in some way.


The term “endogenous” or “native” means that a gene originated from the species in question, without regard to subspecies or strain, although that gene may be naturally or intentionally mutated, or placed under the control of a promoter that results in overexpression or controlled expression of said gene. Thus, genes from Clostridia would not be endogenous to Escherichia, but a plasmid expressing a gene from E. coli or would be considered to be endogenous to any genus of Escherichia, even though it may now be overexpressed.


“Expression vectors” are used in accordance with the art accepted definition of a plasmid, virus or other propagatable sequence designed for protein expression in cells. There are thousands of such vectors commercially available, and typically each has an origin of replication (ori); a multiple cloning site; a selectable marker; ribosome binding sites; a promoter and often enhancers; and the needed termination sequences. Most expression vectors are inducible, although constitutive expressions vectors also exist.


As used herein, “inducible” means that gene expression can be controlled by the hand of man, by adding e.g., a ligand to induce expression from an inducible promoter. Exemplary inducible promoters include the lac operon, inducible by IPTG, the yeast AOX1 promoter inducible with methanol, the strong LAC4 promoter inducible with lactate, and the like. Low level of constitutive protein synthesis may occur even in expression vectors with tightly controlled promoters.


As used herein, an “integrated sequence” means the sequence has been integrated into the host genome, as opposed to being maintained on an expression vector. It will still be expressable, and preferably is inducible as well.


The use of the word “a” or “an” when used in conjunction with the term “comprising” in the claims or the specification means one or more than one, unless the context dictates otherwise.


The term “about” means the stated value plus or minus the margin of error of measurement or plus or minus 10% if no method of measurement is indicated.


The use of the term “or” in the claims is used to mean “and/or” unless explicitly indicated to refer to alternatives only or if the alternatives are mutually exclusive.


The terms “comprise”, “have”, “include” and “contain” (and their variants) are open-ended linking verbs and allow the addition of other elements when used in a claim. The following abbreviations are used herein:















ABBREVIATION
TERM








ACP
Acyl carrier protein



Box-R
Beta oxidation pathway in reverse.



FAS
Fatty acid biosynthesis



GC
Gas chromatograph



HPLC
High pressure liquid chromatograph



ORF
Open reading Frame












BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1. Generalized pathway for the conversion of alkanes to desired products.



FIG. 2. Example of oxygen-independent alkane activation cycle via fumarate addition and conversion to an acyl-CoA, generation of product precursor acetyl-CoA and propionyl-CoA, regeneration of fumarate from propionyl-CoA, and generalized product formation from acetyl-CoA. Enzymes, 1: alkyl succinate synthase, 2a: succinyl-CoA:2-methyl-alkyl-succinyl-CoA transferase/2-methyl-alkyl-succinyl-CoA synthetase, 2b: 2-methyl-alkyl-malonyl-CoA mutase, 2c: 2-methyl-alkyl-malonyl-CoA decarboxylase, 2d: β-oxidation enzymes, 2e: propionyl-CoA carboxylase, 2f: methylmalonyl-CoA epimerase and methylmalonyl-CoA mutase, 2g: succinyl-CoA:2-methyl-alkyl-succinyl-CoA transferase/succinyl-CoA synthetase, 2h: succinate dehydrogenase.



FIG. 3. Example of one specific oxygen-independent alkane activation cycle via fumarate addition and conversion to an acyl-CoA, generation of product precursor acetyl-CoA and pyruvate (a keto acid), regeneration of fumarate from pyruvate, and generalized product formation from acetyl-CoA.



FIG. 4. Example of one specific oxygen-independent alkane activation cycle via fumarate addition and conversion to an acyl-CoA, generation of product precursor acetyl-CoA and propionyl-CoA, regeneration of fumarate from propionyl-CoA, and generalized product formation from acetyl-CoA. Enzymes, 1: methyl succinate synthase, 2: succinyl-CoA:2-methyl-alkyl-succinyl-CoA transferase/2-methyl-alkyl-succinyl-CoA synthetase, 3: 2-methyl-alkyl-succinyl-CoA dehydrogenase, 4: mesaconyl-CoA hydratase/β-methylmalyl-CoA dehydratase, 5: β-methylmalyl-CoA lyase, 6: propionyl-CoA carboxylase, 7: methylmalonyl-CoA epimerase and methylmalonyl-CoA mutase, 8: succinyl-CoA:2-methyl-alkyl-succinyl-CoA transferase/succinyl-CoA synthetase, 9: succinate dehydrogenase, 10: glyoxylate carboligase, 11: tartronate semialdehyde reductase, 12: glycerate kinase, 13: glycolytic enzymes (phosphoglycerate mutase, enolase, pyruvate kinase), 14: pyruvate dehydrogenase or pyruvate formate lyase, 15: β-oxidation reversal or fatty acid biosynthesis pathways with desired termination pathways.



FIG. 5. Oxygen-dependent alkane activation via terminal addition of a hydroxyl group to a primary alcohol and conversion to acyl-CoA, generation of precursor acetyl-CoA, and generalized product synthesis from acetyl-CoA. Enzymes, 1: alkane monooxygenase or alkane hydroxylase, 2: alcohol dehydrogenase, 3: aldehyde dehydrogenase, 4: acyl-CoA synthetase, 5: acylating aldehyde dehydrogenase.



FIG. 6A-D. Vectors expressing the components of the oxygen-independent activation enzyme alkyl-succinate synthase from Azoarcus sp. H×N1. MasB (A9J4K0), MasC (A9J4K2), MasD (A9J4K4), MasE (A9J4K6), and MasG (A9J4J6) have been proposed as required components for enzyme function.



FIG. 7. Expression of components of the alkyl-succinate synthase from Azoarcus sp. H×N1, part of the oxygen-independent alkane activation/utilization pathway. Soluble cell extract of E. coli cells expressing MasB (A9J4K0), MasC (A9J4K2), MasD (A9J4K4), MasE (A9J4K6), and MasG (A9J4J6). Lane 1: pETDuet-1-P1-MasCDEB-P2-MasG; Lane 2: pETDuet-1-P1-MasCDE-P2-MasG; Lane 3: pETDuet-1-P1-MasCDEB; Lane 4: pETDuet-1-P1-MasCDE; Lane 5: pETDuet-1.



FIG. 8A-C. Vectors expressing the components of the oxygen-independent activation enzyme alkyl-succinate synthase from Desulfosarcina sp. BuS5. Proteins identified through similarity to Azoarcus sp. H×N1 MasBCDEG as well as physical location in Desulfosarcina sp. BuS5 genome. Mas5: WP_027352796.1; Mas8: WP_051374532.1; Mas11: WP_027352800.1.



FIG. 9A-C. Vectors expressing the components of the oxygen-independent activation enzyme alkyl-succinate synthase from Desulfosarcina sp. BuS5. Proteins identified through similarity to Azoarcus sp. H×N1 MasBCDEG as well as physical location in Desulfosarcina sp. BuS5 genome. Mas5: WP_027352796.1; Mas4: WP_027352795.1; Mas3: WP_027352794.1; Mas2: WP_027352793.1; Mas8: WP_051374532.1; Mas11: WP_027352800.1.



FIG. 10A-C. Vectors expressing enzymes for the conversion of fumarate activated hydrocarbon intermediates to product precursors. TaBbsEF: T. aromatica succinyl-CoA:(R)-benzylsuccinate CoA-transferase (Q9KJF0, Q9KJE9); RsMcd: R. sphaeroides (2S)-methylsuccinyl-CoA dehydrogenase (ADC44452.1); RsMch: R. sphaeroides mesaconyl-coenzyme A hydratase (Q3IZ78).



FIG. 11. Expression of enzymes involved in the oxygen-independent alkane utilization pathway. Left: Whole cell extract of E. coli cells expressing T. aromatica succinyl-CoA:(R)-benzylsuccinate CoA-transferase TaBbsEF (Q9KJF0, Q9KJE9), Lane 1: pCDFDuet-1-P1-TaBbsEF; Lane 2: pCDFDuet-1. Right: Soluble cell extract of E. coli cells expressing R. sphaeroides (2S)-methylsuccinyl-CoA dehydrogenase RsMcd (ADC44452.1) and R. sphaeroides mesaconyl-coenzyme A hydratase RsMch (Q3IZ78), Lane 1: pCDFDuet-1-P1-P2-RsMch-RsMcd; Lane 2: pCDFDuet-1-P1-P2-RsMch; Lane 3: pCDFDuet-1. RsMcd: R. sphaeroides (2S)-methylsuccinyl-CoA dehydrogenase (ADC44452.1); RsMch: R. sphaeroides mesaconyl-coenzyme A hydratase (Q3IZ78).



FIG. 12. Oxygen-dependent alkane activation of hexane with P. putida alkane hydroxylase AlkBGT. GC-FID chromatogram for products of whole cell biotransformation of BL21(DE3) cells with indicated vectors shown. 1 mL of cell suspension (OD550 nm=12) incubated with 250 μL hexane at 30° C. for 2 hours. Hexanol only observed only in cells expressing AlkBGT.



FIG. 13. Oxygen-dependent alkane activation of pentane with P. putida alkane hydroxylase AlkBGT. GC-FID chromatogram for products of whole cell biotransformation of BL21(DE3) cells with indicated vectors shown. 1 mL of cell suspension (OD550 nm=12) incubated with 250 μL pentane at 30° C. for 2 hours. Pentanol only observed only in cells expressing AlkBGT.



FIG. 14A-B. Vectors expressing the putative alkane monooxygenase from Rhodobacter sphaeroides. RSP2792: monooxygenase alpha subunit (YP_352924.1); RSP2793: monooxygenase reductase component (YP_352923.1); RSP2794: monooxygenase beta subunit (YP_352922.1); RSP2795: regulatory protein of multicomponent monooxygenase (YP_352921.1).



FIG. 15. TABLE G: list of some possible embodiments.





DETAILED DESCRIPTION

The activation of the short chain hydrocarbon substrates, such as methane of LNG components, requires the high stability and low reactivity of hydrocarbon compounds to be overcome through the cleavage of an inert C—H bond. Two main biological approaches can be exploited here for this purpose, 1) the oxygen-independent activation through the addition of fumarate to form a 2-methyl-alkyl-succinyl-CoA, or 2) the oxygen-dependent activation through the terminal addition of a hydroxyl group to the alkane to form a primary alcohol.


The first approach leverages a native pathway for anaerobic hydrocarbon activation used by certain microorganisms for the degradation of C6-C20 alkanes (Callaghan, 2013). In this pathway, an alkyl-succinate synthase first forms a branched methyl-alkyl-succinate adduct from the addition of fumarate to the alkane, with further metabolism and fumarate regeneration steps resulting in the conversion of hydrocarbon substrates to central, intracellular metabolites (FIG. 2).


In order to meet ATP requirements of this cycle, native hydrocarbon degrading microorganisms utilize the electrons generated during substrate oxidation for anaerobic respiration with nitrate, metal ions, or sulfate, thereby making hydrocarbon degradation thermodynamically favorable (Mbadinga et al., 2011). An example of this type of process is found in strain H×N1, which can grow anaerobically on alkanes such as hexane when coupled to denitrification, with the key genes required for initial alkane activation proposed (Grundmann et al., 2008). Reports also have suggested similar activation with shorter chain hydrocarbons in bacterial consortiums, although the enzymes responsible have not been identified (Duncan et al., 2009; Kniemeyer et al., 2007).


Furthermore, several potential variations of this pathway exist in which various biological reactions can be utilized to convert the 2-methyl-alkyl-succinate adduct formed via fumarate addition into central metabolic intermediates (FIG. 3 and FIG. 4). Regardless of the pathway selected, the end result of the oxygen-independent hydrocarbon activation pathway is the formation of an acyl-CoA molecule that can be used to generate the product precursor acetyl-CoA. While in certain cases acetyl-CoA is directly formed as a result of initial acyl-CoA formation (FIG. 3 and FIG. 4), other initial acyl-CoA intermediates require further oxidation for the generation of acetyl-CoA (FIG. 2). In all cases, the end result is the generation of acetyl-CoA to serve as a product precursor, as well as another acyl-CoA of keto-acid compound that can be used for fumarate regeneration.


Considering the use of fumarate in the alkane activation cycle, this oxygen-independent activation approach also requires pathways for the regeneration of this compound from an acyl-CoA or keto-acid. Details on the pathways leading to the regeneration of fumarate from an acyl-CoA, such as propionyl-CoA, or a keto-acid, such as pyruvate, are shown in FIG. 2, FIG. 3, and FIG. 4. This regeneration enables the continued operation of the hydrocarbon activation cycle via fumarate addition.


In contrast to hydrocarbon activation via fumarate addition, an alternative pathway for the cleavage of an inert C—H bond is the use of an oxygen-dependent activation mechanism in which an alkane hydroxylase/monooxygenase adds a terminal alcohol group to the hydrocarbon, which is then further oxidized (FIG. 5). The end result of the oxygen-dependent activation pathway is an acyl-CoA intermediate than can be used for the generation of the product precursor acetyl-CoA. Given the direct use of oxygen in this pathway for activation, no additional pathways are required to regenerate an activation compounds as in the above oxygen-independent approach.


Once the product precursor acetyl-CoA has been formed through the above described approaches, the desired products can then be synthesized through various native or engineered metabolic pathways. These include both the reversal of the β-oxidation cycle and the fatty acid biosynthesis pathway, which both proceed from acetyl-CoA as the starting compound. While the type of condensation reaction for chain elongation varies between the 2 pathways (reversal of the β-oxidation cycle utilizes a non-decarboxylative condensation while the fatty acid biosynthesis pathway employs a decarboxylative condensation), both proceed through a series of condensation, reduction, dehydration, and reduction reactions that result in an intermediate 2 carbons longer than the starting unit. As such, each of these pathways can be exploited for the synthesis of a wide range of products through the selection of termination pathways that convert cycle intermediates to products such as carboxylic acids and alcohols among others.


Thus, either of these product synthesis pathways, combined with the key pathway modules for hydrocarbon activation and conversion to an acyl-CoA intermediate, generation of product precursor acetyl-CoA, and generation of an addition acyl-CoA or keto-acid for fumarate when required, and the formation of a desired product from acetyl-CoA enables an engineered microorganism capable of the conversion of short-chain hydrocarbons (e.g. methane, ethane, propane, butane, pentane) to fuels and chemicals (e.g. carboxylic acids, alcohols, hydrocarbons, and their alpha-, beta-, and omega-functionalized derivatives).


The following description provides additional details, any one of which can be subject to patenting in combination with any other. The specification in its entirety is to be treated as providing a variety of details that can be used interchangeably with other details, as the specification would be of inordinate length if one were to list every possible combination of genes/vectors/enzymes/hosts that can be made to convert short chain hydrocarbons to desired fuels and chemicals of interest. Some possible combinations are listed in Table G, however, (FIG. 15).


Enzymes of interest can be expressed from vectors such as pETDuet-1 or pCDFDuet-1 (MERCK, Germany), which makes use of the DE3 expression system. Genes can be codon optimized according to the codon usage frequencies of the host organism and synthesized by a commercial vendor or in-house. However, thousands of expression vectors and hosts are available, and this is a matter of convenience.


The genes can be amplified by PCR using primers designed with 15-22 base pairs of homology for the appropriate vector cut site. For enzymes that will not require a 6×-histadine tag fusion for purification, pCDFDuet-1 can be linearized with NcoI and EcoRI. Enzymes that will be purified by Ni-NTA column will make use of the 6×-HIS tag in pCDFDuet-1. The vector can be linearized using only EcoRI in this case.


The PCR product can be inserted into the vector using e.g., the In-Fusion HD EcoDry Cloning System and the vector transformed by heat shock into competent E. coli cells. Transformants can be selected on solid media containing the appropriate antibiotic. Plasmid DNA can be isolated using any suitable method, including QIAprep Spin Miniprep Kit (QIAGEN, Limburg), and the construct confirmed by PCR and sequencing. Confirmed constructs can be transformed by e.g., electroporation into a host strain such as E. coli for expression, but other host species can be used with suitable expression vectors and possible codon optimization for that host species.


Expression of the desired enzymes from the constructed strain can be conducted in liquid culture, e.g., shaking flasks, bioreactors, chemostats, fermentation tanks and the like. Gene expression is typically induced by the addition of a suitable inducer, when the culture reaches an OD550 nm of approximately 0.5-0.8. Induced cells can be grown for about 4-8 hours, at which point the cells can be pelleted and saved to −20° C. Expression of the desired protein can be confirmed by running samples on SDS-PAGE.


The expressed enzyme can be directly assayed in crude cell lysates, simply by breaking the cells by chemical, enzymatic, heat or mechanical means. Depending on the expression level and activity of the enzyme, however, purification may be required to be able to measure enzyme activity over background levels. Purified enzymes can also allow for the in vitro assembly of the pathway, allowing for its controlled characterization.


N- or C-terminal HIS-tagged proteins can be purified using e.g., a Ni-NTA Spin Kit (Qiagen, Venlo, Limburg) following the manufacturer's protocol, or other methods could be used. The HIS-tag system was chosen for convenience only, and other tags are available for purification uses. Further, the proteins in the final assembled pathway need not be tagged if they are for in vivo use. Tagging was convenient, however, for the enzyme characterization work performed hereunder.


Reaction conditions for enzyme assays can vary greatly with the type of enzyme to be tested. In general, however, enzyme assays follow a similar general protocol. Purified enzyme or crude lysate is added to suitable reaction buffer. Reaction buffers typically contain salts, necessary enzyme cofactors, and are at the proper pH. Buffer compositions often change depending on the enzyme or reaction type. The reaction is initiated by the addition of substrate, and some aspect of the reaction related either to the consumption of a substrate or the production of a product is monitored.


Choice of the appropriate monitoring method depends on the compound to be measured. Spectrophotometric assays are convenient because they allow for the real time determination of enzyme activity by measuring the concentration dependent absorbance of a compound at a certain wavelength. There are not always compounds with a measureable absorbance at convenient wavelengths in the reaction, unfortunately. In these situations, other methods of chemical analysis may be necessary to determine the concentration of the involved compounds.


As an example, cultures for enzymatic assays were conducted in 125 ml Erlenmeyer flasks containing 25 mL LB media inoculated at 3% from an overnight culture. E. coli strains containing constructs expressing genes of interest were grown under appropriate conditions until an optical density of ˜0.5 was reached, at which point inducer(s) were added and the cells incubated for an additional 4 hrs. Cell harvesting and preparation of crude cell extracts for enzyme assays was conducted as described elsewhere (Dellomonaco et al., 2011). Enzymatic reactions were then monitored on either a Synergy HT plate reader (BioTek Instruments, Inc., Winooski, VT) or a Biomate 5 Spectrophotometer (Thermo Scientific, Waltham, MA) according to established protocols.


Furthermore, whole cell biotransformations represent another method to determine enzyme/pathway functionality. As an example, biotransformations for alkane activation were conducted using E. coli BL21(DE3) with appropriate vectors. 750 μL of an overnight LB culture with appropriate antibiotics was used to inoculate 25 mL LB media with 10 μM FeSO4 in a 125 mL Pyrex Erlenmeyer flask. Flasks were incubated at 37° C. and 200 rpm in an NBS Benchtop Incubator Shaker until an optical density of ˜0.5 was reached, at which point appropriate inducers were added. Cultures were grown for 4 hrs post-induction and then centrifuged (8000 rpm, 22° C., 5 min) and re-suspended to an optical density ˜12 in 100 mM KPi buffer (pH 7.0) with 1% glycerol (Koch et al., 2009). 250 μL alkane was then added to a 2 mL cell suspension in a 5 mL glass vial and incubated with rotation (60 rpm) at 30° C. for 2 hrs. Following the biotransformations, products (alcohols) were extracted and analyzed as previously described (Kim et al., 2015).


Gas chromatography (GC) is convenient for the quantification of volatile substances, of which fatty acids and alcohols are of particular relevance. Internal standards, typically one or more molecules of similar type not involved in the reaction, are added to the reaction mixture, and the reaction mixture is extracted with an organic solvent, such as hexane. Fatty acid samples, for example, can be dried under a stream of nitrogen and converted to their trimethylsilyl derivatives using N,O-Bis(trimethylsilyl)trifluoroacetamide (BSTFA) and pyridine in a 1:1 ratio. After 30 minutes incubation, the samples are once again dried and resuspended in hexane to be applied to the gas chromatograph (GC). Aldehyde samples do not need to be derivatized. Samples can be run e.g., on a Varian CP-3800 gas chromatograph (VARIAN ASSOCIATES, Palo Alto, CA) equipped with a flame ionization detector and HP-5 capillary column (AGILENT TECH., CA).


Once pathways have been fully studied in vitro, they can be constructed in vivo with greater confidence. The strain construction for the in vivo pathway operation should allow for the well-defined, controlled expression of the enzymes of the pathway. As before, E. coli or yeast will be a host of choice for the in vivo pathway, but other hosts could be used. The Duet system, for example, allows for the simultaneous expression of up to eight proteins by induction with IPTG in E. coli, and initial experiments will use this host.


Pathway enzymes can also be inserted into the host chromosome, allowing for the maintenance of the pathway without requiring antibiotics to ensure the continued upkeep of plasmids. A large number of genes that can be placed on the chromosome, as chromosomal expression does not require separate origins of replication as is the case with plasmid expression.


DNA constructs for chromosomal integration usually include an antibiotic resistance marker with flanking FRT sites for removal, as described by Datsenko and Wanner, a well characterized promoter, a ribosome binding site, the gene of interest, and a transcriptional terminator. The overall product is a linear DNA fragment with 50 base pairs of homology for the target site on the chromosome flanking each side of the construct.


However, the Flp-FRT recombination method is only one system for adding genes to a chromosome, and other systems are available, such as the RecBCD pathway, the RecF pathway, RecA recombinase, non-homologous end joining (NHEJ), Cre-Lox recombination, TYR recombinases and integrases, SER resolvases/invertases, SER integrases, PhiC31 Integrase, and the like. Chromosomal modifications in E. coli can also achieved by the method of recombineering, as originally described by Datsenko and Wanner.


In a recombineering method, for example, the cells are prepared for electroporation following standard techniques, and the cells transformed with linear DNA that contains flanking 50 base pair targeting homology for the desired modification site. For seamless integration of a DNA construct, a two-step approach can be taken using a cassette that contains both positive and negative selection markers, such as the combination of cat and sacB. In the first round of recombineering, the cat-sacB cassette with targeting homology for the desired modification site is introduced to the cells. The cat gene provides resistance to chloramphenicol, which allows for positive recombinants to be selected for on solid media containing chloramphenicol.


A positive isolate can be subjected to a second round of recombineering introducing the desired DNA construct with targeting homology for sites that correspond to the removal of the cat-sacB cassette. The sacB gene encodes for an enzyme that provides sensitivity to sucrose. Thus, growth on media containing sucrose allows for the selection of recombinants in which the cat-sacB construct was removed. Pl phage lysates can be made from isolates confirmed by PCR and sequencing. The lysates can be used to transduce the modification into desired strains, as described previously.


Engineered strains expressing the designed pathway can be cultured under the following or similar conditions. Overnight cultures started from a single colony can be used to inoculate flasks containing appropriate media. Cultures are grown for a set period of time, and the culture media analyzed. The conditions will be highly dependent on the specifications of the actual pathway and what exactly is to be tested. For example, the ability for the pathway to be used for hydrocarbon utilization can be tested by the use of short-chain alkanes as a substrate in MOPS minimal media, as described by Neidhardt, supplemented with appropriate antibiotics, and inducers.


Analysis of culture media after fermentation provides insight into the performance of the engineered pathway. Quantification of hydrocarbons and longer chain fatty acid and alcohol products can be analyzed by GC. Other metabolites, such as short chain organic acids and alcohols can be analyzed by high pressure liquid chromatograph (HPLC). Once the pathway is fully functional, the cultures can be grown in chemostat, providing continuous uninterrupted production of product if desired.


Various—omics techniques, such as microarray or 2D-PAGE can give information about gene expression or protein expression, respectively. Genome scale modeling allows for the identification of additional modifications to the host strain that might lead to improved performance. Deletion of competing pathways, for example, might increase carbon flux through the engineered pathway for product production.


Standard molecular biology techniques were used for gene cloning, plasmid isolation, and E. coli transformation. Native E. coli genes were amplified from E. coli MG1655 genomic DNA using primers to append 15 bp of homology on each end of the gene insert for recombination into the vector backbone. Genes from other organisms were codon optimized and synthesized by either GeneArt (LIFE TECH., CA or GENSCRIPT, NJ). Plasmids were linearized by the appropriate restriction enzymes and recombined with the gene inserts using the In-Fusion HD Eco-Dry Cloning system (CLONTECH LAB. CA,). The mixture was subsequently transformed into Stellar competent cells (CLONTECH LAB.).


Transformants that grew on solid media (LB+Agar) supplemented with the appropriate antibiotic were isolated and screened for the gene insert by PCR. Plasmid was isolated from the verified transformants and the sequence of the gene insert was further confirmed by DNA sequencing (LONE STAR LABS, TX). Plasmids (also referred to as vectors) in each case contain at least one promoter, a ribosome binding site for each gene, the gene(s) of interest, at least one terminator, an origin of replication, and an antibiotic resistance marker. Exemplary plasmids are shown in FIGS. 6A-D, 8A-C, 9A-C, 10A-C and 14.


Genes that encode the enzymes of the engineered pathway were cloned and expressed as described above. The crude protein extracts or purified enzymes were assessed for their ability to catalyze the proposed reactions. Tables β-F below describe the characterization of enzymes for required pathway steps depicted in FIG. 2, FIG. 3, FIG. 4, and FIG. 5. In addition to the experimental data provided, several literature examples are listed to provide additional evidence to the ability of known enzymes to possess the required enzymatic activity of several pathway steps. Thus, a great variety of enzymes are exemplified herein.


TABLE B describes the characterization of enzymes involved in hydrocarbon activation/utilization and conversion to acyl-CoA intermediates through the fumarate addition pathway as depicted in FIG. 2.









TABLE B







Characterization of enzymes involved in the pathway for bioconversion of hydrocarbons via fumarate


addition as depicted in FIG. 2
















Measured specific



Enzyme



activity (μmol/mg



Number
Enzyme class
Enzyme
Substrate
protein/min)
Reference












1
alkylsuccinate synthase
See Table C for details












2a
succinyl-CoA: 2-methyl-alkyl-

T. aromatica

Methylsuccinate
Methylsuccinyl-CoA
Leutwein and



succinyl-CoA transferase/2-
BSCT
and succinyl-CoA
formation observed
Heider (2001)



methyl-alkyl-succinyl-CoA







synthetase






2b
2-methyl-alkyl-malonyl-CoA

R. Sphaeroides

ethylmalonyl-CoA
0.05, Km: 60 μM
Erb et al (2008)



mutase
Ecm

(methylsuccinyl-CoA







product)



2c
2-methyl-alkyl-malonyl-CoA

M. musculus

ethylmalonyl-CoA
8800, Km: 0.96 μM
Linster et al



decarboxylase
ECHDC1


(2011)





methylmalonyl-
Km: 3.1 μM
Linster et al





CoA

(2011)


2e
propionyl-CoA carboxylase

M. sedula Pcc

propionyl-CoA
3.3, Km: 70 μM
Hugler et al






(75° C.)
(2003)





S. coelicolor Pcc

propionyl-CoA
0.2, Km: 76 μM
Arabolaza et al







(2010)


2f
methylmalonyl-CoA epimerase

P. horikoshii Mce

(S)-2-
162, Km: 79 μM 
Bobik and





methylmalonyl-

Rasche (2004)





CoA





methylmalonyl-CoA mutase

P. freudenreichii

(R)-2-
26, Km: 124 μM
Chowdhury et al




subsp. shermanii
methylmalonyl-

(1999); Padovani




Mcm
CoA

et al (2006)


2g
succinyl-CoA: 2-methyl-alkyl-

E. coli SucCD

Succinate
18.6, Km: 141 μM
Nolte at al



succinyl-CoA

(reversible

(2014)



transferase/succinyl-CoA

reaction)





synthetase






2h
succinate dehydrogenase

E. coli SdhCDAB

succinate
Km: 2.5 μM
Maklashina at al







(2001)







2d: β-oxidation enzymes













Acyl-CoA dehydrogenase

E. coli FadE

butyryl-CoA
0.008 ± 0.001
This work



Enoyl-CoA hydratase

E. coli FadB

crotonyl-CoA
0.051 ± 0.004
This work



3-hydroxyacyl-CoA

E. coli FadB

3-hydroxybutyryl-
0.185 ± 0.001
This work



dehydrogenase

CoA





3-ketoacyl-CoA thiolase

E. coli AtoB

acetoacetyl-CoA
17.1 ± 1.2 
This work





E. coli FadA

acetoacetyl-CoA
0.013 ± 0.002
This work





R. eutropha BktB

acetoacetyl-CoA
27.0 ± 1.1 
This work





S. collinus FadA

acetoacetyl-CoA
115.6 ± 1.0 
This work





P. putida FadAx

acetoacetyl-CoA
30.9 ± 0.3 
This work









Additional details on alkylsuccinate synthase enzymes, required for the activation of hydrocarbons via fumarate addition are provided in TABLE C:









TABLE C







Observed alkane activation via fumarate addition (alkylsuccinate synthases)











Hydro-






carbon






Substrate
Organism(s)
Product
Literature Evidence
Reference





Methane
bacterial consortium
methylsuccinate
Product detected (2.08 μM) in
Duncan at al.



(Alaskan North Slope)

oil field sample
(2009)



bacterial consortium
methylsuccinate
Product detected in production
Bian at al





field sample from oil reservoir
(2015)


Ethane
bacterial consortium
ethylsuccinate
Product detected (1.77 μM) in
Duncan et al.



(Alaskan North Slope)

oil field sample
(2009)



bacterial consortium
ethylsuccinate
Product detected in production
Bian et al





field sample from oil reservoir
(2015)


Propane
bacterial consortium
methylethylsuccinate
Product detected (2.18 μM) in
Duncan et al.



(Alaskan North Slope)

oil field sample
(2009)




Desulfosarcina sp. BuS5

methylethylsuccinate/n-
Terminal and sub-terminal
Kniemeyer et




propylsuccinate
product formation from bacterial
al. (2007)





cultures




bacterial consortium
methylethylsuccinate
Product detected in production
Bian et al





field sample from oil reservoir
(2015)


Butane
bacterial consortiums
methylpropylsuccinate
Product detected (0.76 μM) in
Duncan et al.



(Alaskan North Slope)

field sample
oil (2009)




Desultosarcina sp. BuS5

methylpropylsuccinate
Terminal and sub-terminal
Kniemeyer et





product formation from bacterial
al. (2007)





cultures




bacterial consortium
methylpropylsuccinate
Product detected in production
Bian et al





field sample from oil reservoir
(2015)


Pentane

Azoarcus sp. H × N1

Methylbutylsuccinate
Product formation from crude
Webner (2012)





enzyme assay (~5% relative to






hexane)




bacterial consortium
methylbutylsuccinate
Product detected in production
Bian et al





field sample from oil reservoir
(2015)


Hexane

Azoarcus sp. H × N1

methylpentylsuccinate
Product formation from crude
Webner (2012)





enzyme assay (55 μM in crude






extract assays)




bacterial consortium
methylpentylsuccinate
Product detected in production
Bian et al





field sample from oil reservoir
(2015)


Heptane

Azoarcus sp. H × N1

methylhexylsuccinate
Product formation from crude
Webner (2012)





enzyme assay (~120% relative






to hexane)




bacterial consortium
methylhexylsuccinate
Product detected in production
Bian et al





field sample from oil reservoir
(2015)


Octane

Azoarcus sp. H × N1

methylheptylsuccinate
Product formation from crude
Webner (2012)





enzyme assay (~50% relative






to hexane)




bacterial consortium
methylheptylsuccinate
Product detected in production
Bian at al





field sample from oil reservoir
(2015)









Included in these alkylsuccinate synthase enzymes are those from Azoarcus sp. H×N1 (Grundmann et al., 2008) and Desulfosarcina sp. BuS5 (Kniemeyer et al., 2007) for which the catalytic subunit, and associated subunits for the case of Azoarcus sp. H×N1, have been proposed. Genes encoding the proposed subunits of the Azoarcus sp. H×N1 alkylsuccinate synthase have been cloned into required expression vectors as shown in FIG. 6. Evaluation of the expression of alkylsuccinate synthase subunits in E. coli is shown in FIG. 7.


Furthermore, several candidate alkylsuccinate synthase subunits and associated proteins have been identified through a BLAST search of Azoarcus sp. H×N1 alkylsuccinate synthase subunits against the recently sequenced Desulfosarcina sp. BuS5 genome, a strain that degrades propane and butane via fumarate addition. This search identified several enzymes within close physical proximity to the large catalytic MasD subunit (WP_027352796.1), including 2 enzymes with high similarity to the Azoarcus sp. H×N1MasE subunit (WP_027352794.1 and WP_027352793.1), a protein with similarity to alkylsuccinate synthase gamma subunits from Desulfatibacillum alkenivorans AK-01 and Smithella sp. SCADC (WP_027352795.1), and enzymes with similarity to the Azoarcus sp. H×N1 MasG activating enzyme (WP_051374532.1) and other radical SAM enzymes (WP_027352800.1). In all, 13 proteins appear to be encoded from an operon within the Desulfosarcina sp. BuS5 genome spanning the locus from 66239-79342 in the associated genome sequence NZ_AXAM01000003.1. Genes encoding potential subunits of the alkylsuccinate synthase (WP_027352793.1, WP_027352794.1, WP_027352795.1, and WP_027352796.1) and activation enzyme (WP_051374532.1 and WP_027352800.1) have been cloned into required expression vectors as shown in FIG. 8 and FIG. 9.


This type of homology search can be further exploited to identify other potential alkylsuccinate synthase enzymes/operons through a BLAST search of these enzymes against other hydrocarbon degrading species. For example, a search of the Desulfosarcina sp. BuS5 MasD subunit (WP_027352796.1) was used to identify potential MasD subunits from species such as Peptococcaceae bacterium SCADC1_2_3 (WP_036734374.1), Desulfoglaeba alkanexedens ALDC (ADJ51097.1), and Peptococcaceae bacterium BRH_c4a (KJS01634.1), among others.


Furthermore, additional enzymes required for conversion of fumarate activated hydrocarbon intermediates to product precursors have been investigated. Enzymes such as T. aromatica succinyl-CoA:(R)-benzylsuccinate CoA-transferase (Q9KJF0, Q9KJE9), R. sphaeroides (2S)-methylsuccinyl-CoA dehydrogenase (ADC44452.1), and R. sphaeroides mesaconyl-coenzyme A hydratase (Q3IZ78) enable the conversion of the fumarate activated hydrocarbons to product precursors, which can then be converted to desired products. Genes encoding the above proteins have been cloned into required expression vectors (FIG. 10A-C) and their expression in E. coli evaluated (FIG. 11).


The above described enzymes for hydrocarbon activation/utilization and conversion to acyl-CoA intermediates through the fumarate addition pathway provide a route for the bioconversion of short-chain hydrocarbons of varying chain length. For the specific case of methane activation/utilization, the pathways depicted in FIG. 3 and FIG. 4 can also be exploited for the conversion of fumarate activated methane into product precursors as well as for the regeneration of fumarate. TABLE D and TABLE E describe the characterization of enzymes involved in these versions of the bioconversion pathway:









TABLE D







Characterization of enzymes involved in the pathway for bioconversion of hydrocarbons


via fumarate addition as depicted in FIG. 3














Measured specific activity



Enzyme name
Enzyme
Substrate
(μmol/mg protein/min)
Reference











alkylsuccinate synthase
See Table B for details











succinyl-CoA: 2-methyl-alkyl-

T. aromatica

Methylsuccinate
Methylsuccinyl-CoA
Leutwein and


succinyl-CoA






transferase/2-methyl-alkyl-succinyl-
BSCT
and succinyl-
formation observed
Heider (2001)


CoA synthetase

CoA




2-methyl-alkyl-succinyl-CoA

R. sphaeroides

(2S)-
mesaconyl-CoA formation
Erb et al (2009)


dehydrogenase
Mcd
methylsuccinyl-
observed





CoA




mesaconyl-C1-CoA-C4 transferase

C. aurantiacus

mesaconyl-C1-
mesaconyl-C4-CoA
Zarzycki et al (2009)



Mct
CoA
formation observed



mesaconyl-C4-CoA hydratase

C. aurantiacus

mesaconyl-C4-
(S)-citramalyl-CoA
Zarzycki et al (2009)



Meh
CoA
formation observed



L-malyl-CoA/citramalyl-CoA lyase

C. aurantiacus

(S)-citramalyl-
Acetyl-CoA and pyruvate
Zarzycki et al (2009)



Mmc
CoA
formation observed



pyruvic-malic carboxylase

E. coli MaeA

pryuvate
1.3, Km: 16 mM
Stols and Donnelly






(1997)


fumarase

E. coli FumA

L-malate
706, Km: 700 mM
van Vugt-






Lussenburg et al






(2013)
















TABLE E







Characterization of enzymes involved in the pathway for bioconversion of hydrocarbons via fumarate


addition as depicted in FIG. 4
















Measured specific



Enzyme



activity (μmol/mg



Number
Enzyme class
Enzyme
Substrate
protein/min)
Reference












1
alkylsuccinate synthase
See Table C for details












2
succinyl-CoA:2-methyl-alkyl-

T. aromatica

Methylsuccinate
Methylsuccinyl-CoA
Leutwein and



succinyl-CoA transferase/2-methyl-
BSCT
and succinyl-CoA
formation observed
Heider (2001)



alkyl-succinyl-CoA synthetase






3
2-methyl-alkyl-succinyl-CoA

R. sphaeroides

(2S)-
mesaconyl-CoA
Erb et al (2009)



dehydrogenase
Mcd
methylsuccinyl-
formation observed






CoA




4
mesaconyl CoA hydratase/β

R. sphaeroides

β methylmalyl
1400, mesaconyl CoA
Zarzycki et al



methylmalyl-CoA dehydratase
Mch
CoA (reverse
formation observed
(2008)





reaction)




5
β-methylmalyl-CoA lyase

R. sphaeroides

β-methylmalyl-
26, Km: 10 μM
Erb et al (2010)




Mcl1
CoA




6
propionyl-CoA carboxylase

M. sedula Pcc

propionyl-CoA
3.3, Km: 70 μM
Hugler et al






(75° C.)
(2003)





S. coelicolor

propionyl-CoA
0.2, Km: 76 μM
Arabolaza et al




Pcc


(2010)


7
methylmalonyl-CoA epimerase

P. horikoshii

(S)-2-
162, Km: 79 μM
Bobik and Rasche




Mce
methylmalonyl-

(2004)





CoA





methylmalonyl-CoA mutase
P.
(R)-2-
26, Km: 124 μM
Chowdhury et al





freudenreichii

methylmalonyl-

(1999); Padovani




subsp.
CoA

et al (2006)




shermanii







Mcm





8
succinyl-CoA:2-methyl-alkyl-

E. coli SucCD

Succinate
18.6, Km: 141 μM
Nolte et al (2014)



succinyl-CoA transferase/succinyl-

(reversible





CoA synthetase

reaction)




9
succinate dehydrogenase

E. coli

succinate
Km: 2.5 μM
Maklashina et al




SdhCDAB


(2001)


10
glyoxylate carboligase

E. coli Gcl

glyoxylate
17.5, Km: 900 μM
Kaplun et al







(2008)


11
tartronate semialdehyde reductase

E. coli GarR

tartronate
Km: 280 μM
Njau et al (2000)





semialdehyde




12
glycerate kinase

E. coli GlxK

D-glycerate
Km: 70 μM
Ornston and







Ornston (1969)









Together, these enzymatic components described above provide a full route for the conversion of short chain hydrocarbons to acyl-CoA (e.g. acetyl-CoA) product precursors, which can subsequently be converted into fuels and chemicals (e.g. carboxylic acids, alcohols, hydrocarbons, and their alpha-, beta-, and omega-functionalized derivatives) through numerous product synthesis pathways, such as beta-oxidation reversal (BOX-R) or fatty acid biosynthesis. BOX-R is not described in great detail herein, since it has been described in the inventor's prior patents and publications.


The use of an oxygen-dependent activation mechanism in which an alkane hydroxylase adds a terminal alcohol group to the hydrocarbon can also be exploited for the bioconversion of short chain hydrocarbons to fuels and chemicals as depicted in FIG. 5. Characterization of required enzymes for hydrocarbon activation and conversion to product precursors is shown in TABLE F:









TABLE F







Characterization of enzymes involved in the pathway for bioconversion of hydrocarbons via


hydroxylation as depicted in FIG. 5
















Measured specific



Enzyme



activity (μmol/mg



Number
Enzyme class
Enzyme
Substrate
protein/min)
Reference















1
alkane monooxygenase

M. capsulatus (Bath)

Methane
Km,methane: 3 μM
Green and



or alkane hydroxylase
sMMO


Dalton (1986)





M. capsulatus (Bath)


0.139 ± 0.005
Sirajuddin et




pMMO


al. (2014)





Thauera butanivorans


Km,methane: 1100 μM
Cooley et al.




sBMO


(2009)





Thauera butanivorans

Ethane
Km,methane: 2.2 μM
Cooley et al.




sBMO


(2009)





P. putida AlkBFG

Propane
Propanol formation
Koch et al.






observed
(2009)





Mycobacterium sp.


Propanol formation
Koch et al.




strain HXN-1500

observed
(2009)




CYP153A6








Thauera butanivorans


Km,propane: 0.94 μM
Cooley et al.




sBMO


(2009)





P. putida AlkBFG

Butane
Butanol formation
Koch et al.






observed
(2009)





Mycobacterium sp.


Butanol formation
Koch et al.




strain HXN-1500

observed
(2009)




CYP153A6








Thauera butonivorans


Km,butane: 0.24 μM
Cooley et al.




sBMO


(2009)





P. putida AlkBGT

Pentane
Pentanol formation
This work






observed, see FIG. 13






P. putida AlkBGT

Hexane
Hexanol formation
This work






observed, see FIG. 12



2
alcohol dehydrogenase

E. coli FucO

butryaldehyde
5.08 ± 0.08
This work


3
Coenzyme A-acylating

L. Reuteri PduP

propionaldehyde
 25 ± 0.2,
Sabet-Azad et



aldehyde dehydrogenase


Km: 28 mM
al. (2013)


4
acyl-CoA synthetase

E. coli Acs

acetate
Km: 200 μM
Brown et al.







(1977)





P. Aeruginosa butyryl-

butyrate
0.255, Km: 10 μM
Shimizu et al.




CoA synthetase


(1981)


5
acylating aldehyde

E. coli AdhE

butyryl-CoA
0.073 ± 0.00 
This work



dehydrogenase

E. coli MhpF

butyryl-CoA
0.009 ± 0.003
This work







β-oxidation enzymes













Acyl-CoA dehydrogenase

E. coli FadE

butyryl-CoA
0.008 ± 0.001
This work



Enoyl-CoA hydratase

E. coli FadB

crotonyl-CoA
0.051 ± 0.004
This work



3-hydroxyacyl-CoA

E. coli FadB

3-hydroxybutyryl-
0.185 ± 0.001
This work



dehydrogenase

CoA





3-ketoacyl-CoA thiolase

E. coli AtoB

acetoacetyl-CoA
17.1 ± 1.2 
This work





E. coli FadA

acetoacetyl-CoA
0.013 ± 0.002
This work





R. eutropha BktB

acetoacetyl-CoA
27.0 ± 1.1 
This work





S. collinus FadA

acetoacetyl-CoA
115.6 ± 1.0 
This work





P. putida FadAx

acetoacetyl-CoA
30.9 ± 0.3 
This work









In addition to the demonstrated activation of hydrocarbon such as pentane and hexane to the associated alcohols, the enzymes required for the conversion of these alcohols to product precursors have also been characterized. The combination of these enzymatic components provide a full route for the conversion of short chain hydrocarbons to acyl-CoA (e.g. acetyl-CoA) product precursors, which can subsequently be converted into fuels and chemicals (e.g. carboxylic acids, alcohols, hydrocarbons, and their alpha-, beta-, and omega-functionalized derivatives) through numerous product synthesis pathways, such as beta-oxidation reversal or fatty acid biosynthesis.


The enzymes described in TABLE F represent a number of examples of enzymes with required pathway activity, however this list is not representative of all available enzymes. Many additional enzymes have been shown to possess the required activities in literature and as such, can easily be integrated with the pathway framework. Furthermore, sequence similarity can also be used for the identification of additional enzymes. As an example, components of putative alkane monooxygenase system in Rhodobacter sphaeroides were identified through a BLAST using the soluble methane monoxygenase (sMMO) system of Methylococcus capsulatus (Bath). Required hydroxylase alpha (YP_352924.1) and reductase (YP_352923.1) subunits were identified, which are part of a 4 gene operon also including a hydroxylase beta subunit (YP_352922.1) and a regulatory protein (YP_352921.1). Genes encoding potential subunits this putative alkane monooxygenase have been cloned into required expression vectors as shown in FIG. 14A-B.


By exploiting either of these hydrocarbon activation described above, various fuels and chemicals (e.g. carboxylic acids, alcohols, hydrocarbons, and their alpha-, beta-, and omega-functionalized derivatives) can be synthesized from short-chain hydrocarbons through the metabolic pathways described and demonstrated herein.


Each of the following is incorporated by reference herein in its entirety for all purposes:

    • U.S. 61/440,192, filed Feb. 7, 2011, WO2013036812, US 20130316413 Reverse beta oxidation pathway by Clomburg et al.
    • U.S. 61/531/911, filed Sep. 7, 2011, WO2013036812 US 20140273110 Functionalized carboxylic acids and alcohols by reverse fatty acid oxidation by Gonzalez & Clomburg
    • 61/932,057, filed Jan. 27, 2014, WO2015112988, Type II fatty acid synthesis enzymes in reverse beta-oxidation by Gonzalez & Clomburg


All accession numbers (generally in brackets after a gene or protein) are expressly incorporated by reference for all purposes herein. Inclusion of the information at each accession entry, would render the patent of inordinate length, and thus, incorporation of all sequences (and other information found therein) by reference is preferred. A person of ordinary skill in the art will recognize the accession numbers and be able to access them from a variety of databases.

    • Arabolaza A, et al., (2010) Crystal structures and mutational analyses of acyl-CoA carboxylase beta subunit of Streptomyces coelicolor. Biochemistry 49, 7367-7376
    • Bian XY, et al., (2015) Insights into the anaerobic biodegradation pathway of n-alkanes in oil reservoirs by detection of signature metabolites. Sci Rep 5
    • Bobik TA & Rasche ME (2004) Purification and partial characterization of the Pyrococcus horikoshii methylmalonyl-CoA epimerase. Appl Microbiol Biotechnol 63, 682-685
    • Brown TD, et al., (1977). The enzymic interconversion of acetate and acetyl-coenzyme A in Escherichia coli. J Gen Microbiol 102(2), 327-36
    • Callaghan AV (2013) Enzymes involved in the anaerobic oxidation of n-alkanes: from methane to long-chain paraffins. Front Microbiol 4(89), 10-3389
    • Chowdhury S & Banerjee R (1999) Role of the dimethylbenzimidazole tail in the reaction catalyzed by coenzyme B12-dependent methylmalonyl-CoA mutase Biochemistry 38, 15287-15294
    • Cooley RB, et al., (2009) Kinetic characterization of the soluble butane monooxygenase from Thauera butanivorans, formerly ‘Pseudomonas butanovora’. Microbiology 155, 2086-96
    • Datsenko KA & Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. PNAS 97(12), 6640-5
    • Dellomonaco C, et al., (2011) Engineered reversal of the beta-oxidation cycle for the synthesis of fuels and chemicals. Nature 476, 355-359
    • Duncan KE, et al., (2009) Biocorrosive thermophilic microbial communities in Alaskan North Slope oil facilities. Environ Sci Technol 43, 7977-84
    • Erb TJ, et al., (2010) The apparent malate synthase activity of Rhodobacter sphaeroides is due to two paralogous enzymes, (3S)-malyl-coenzyme A (CoA)/β-methylmalyl-CoA lyase and (3S)-malyl-CoA thioesterase. J Bacteriol 192, 1249-58
    • Erb TJ, et al., (2009) (2S)-Methylsuccinyl-CoA dehydrogenase closes the ethylmalonyl-CoA pathway for acetyl-CoA assimilation. Mol Microbiol 73, 992-1008
    • Erb TJ, et al., (2008) Ethylmalonyl-CoA mutase from Rhodobacter sphaeroides defines a new subclade of coenzyme B12-dependent acyl-CoA mutases. J Biol Chem 283, 32283-32293
    • Green J & Dalton H. (1986) Steady-state kinetic analysis of soluble methane mono-oxygenase from Methylococcus capsulatus (Bath). Biochem J 236, 155-62
    • Grundmann O, et al., (2008) Genes encoding the candidate enzyme for anaerobic activation of n-alkanes in the denitrifying bacterium, strain H×N1. Environ Microbiol 10(2), 376-85
    • Hugler M, et al., (2003) Characterization of acetyl-CoA/propionyl-CoA carboxylase in Metallosphaera sedula. Carboxylating enzyme in the 3-hydroxypropionate cycle for autotrophic carbon fixation. Eur J Biochem 270, 736-744
    • Kaplun A, et al., (2008) Glyoxylate carboligase lacks the canonical active site glutamate of thiamine-dependent enzymes. Nat Chem Biol 4, 113-118
    • Kim S, et al., (2015) Synthesis of medium-chain length (C6-C10) fuels and chemicals via β-oxidation reversal in Escherichia coli. J Ind Microbiol Biotechnol 42(3), 465-75
    • Kniemeyer O, et al., (2007) Anaerobic oxidation of short-chain hydrocarbons by marine sulphate-reducing bacteria. Nature 449, 898-901
    • Koch DJ, et al., (2009) In vivo evolution of butane oxidation by terminal alkane hydroxylases AlkB and CYP153A6. Appl Environ Microbiol 75, 337-44
    • Leutwein C & Heider J (2001) Succinyl-CoA:(R)-benzylsuccinate CoA-transferase: an enzyme of the anaerobic toluene catabolic pathway in denitrifying bacteria. J Bacteriol 183, 4288-4295
    • Lian J & Zhao Z, (2014) Reversal of the β-Oxidation Cycle in Saccharomyces cerevisiae for Production of Fuels and Chemicals, ACS Synth. Biol. 4 (3): 332-341
    • Linster CL, et al., (2011) Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading J Biol Chem 286, 42992-43003
    • Maklashina E, et al., (2001) Retention of heme in axial ligand mutants of succinate-ubiquinone oxidoreductase (complex II) from Escherichia coli J Biol Chem 276, 18968-18976
    • Mbadinga SM, et al., (2011) Microbial communities involved in anaerobic degradation of alkanes. Int Biodeterior Biodegrad 65(1), 1-13
    • Neidhardt FC, et al., (1974) Culture Medium for Enterobacteria. J Bacteriol 119(3), 736-747
    • Njau RK, et al., (2000) Novel beta-hydroxyacid dehydrogenases in Escherichia coli and Haemophilus influenza. J Biol Chem 275, 38780-6.
    • Nolte JC, et al., (2014) Novel characteristics of succinate coenzyme A (succinate-CoA) ligases: conversion of malate to malyl-CoA and CoA-thioester formation of succinate analogues in vitro. Appl Environ Microbiol 80, 166-176
    • Ornston MK & Ornston LN (1969) Two forms of D-glycerate kinase in Escherichia coli. J Bacteriol 97, 1227-33
    • Padovani D & Banerjee R (2006) Alternative pathways for radical dissipation in an active site mutant of B12-dependent methylmalonyl-CoA mutase Biochemistry 45, 2951-2959
    • Sabet-Azad R, et al., (2013). Coenzyme A-acylating propionaldehyde dehydrogenase (PduP) from Lactobacillus reuteri: kinetic characterization and molecular modeling. Enzyme Microb Technol 53(4), 235-242
    • Shimizu S, et al., (1981). Butyryl-CoA synthetase of Pseudomonas aeruginosa. Purification and characterization. Biochem Biophys Res Commun 103, 1231-1237
    • Sirajuddin S, et al., (2014) Effects of zinc on particulate methane monooxygenase activity and structure. J Biol Chem 289, 21782-94.
    • Stols L & Donnelly MI (1997) Production of succinic acid through overexpression of NAD (+)-dependent malic enzyme in an Escherichia coli mutant. Appl Environ Microbiol 63, 2695-701
    • van Vugt-Lussenburg BM, et al., (2013) Biochemical similarities and differences between the catalytic [4Fe-4S] cluster containing fumarases FumA and FumB from Escherichia coli. PloS One 8, e55549
    • Webner K (2012) Die Gene der (1-Methylalkyl)succinat-Synthase im anaeroben n-Alkanabbau des Betaproteobakteriums Stamm H×N1: Universität Bremen
    • Zarzycki J, et al., (2009) Identifying the missing steps of the autotrophic 3-hydroxypropionate CO2 fixation cycle in Chloroflexus aurantiacus. PNAS 106, 21317-22.
    • Zarzycki J, et al., (2008) Mesaconyl-coenzyme A hydratase, a new enzyme of two central carbon metabolic pathways in bacteria. J Bacteriol 190, 1366-1374

Claims
  • 1-116. (canceled)
  • 117. A genetically engineered microorganism converting an alkane substrate to a product, said microorganism comprising enzymes or overexpressed enzymes catalyzing: a) a sequence of reactions for the oxygen-independent activation of the alkane via fumarate addition to a 2-methyl-alkyl-succinate and subsequent conversion of said 2-methyl-alkyl-succinate to an acyl-CoA, wherein the alkane is a C1-C5 alkane;b) a sequence of reactions for the generation of product precursor acetyl-CoA and an acyl-CoA or keto-acid from said acyl-CoA;c) a sequence of reactions for the regeneration of fumarate through the conversion of said acyl-CoA or keto-acid to fumarate; andd) a sequence of reactions for the formation of a desired product from said product precursor acetyl-CoA.
  • 118. The microorganism of claim 117, wherein said enzymes catalyzing the sequence of reactions for the oxygen-independent activation and the conversion to the acyl-CoA comprise: a. an overexpressed alkyl succinate synthase that catalyzes the addition of fumarate to the alkane to produce a 2-methyl-alkyl-succinate;b. an overexpressed succinyl-CoA:2-methyl-alkyl-succinyl-CoA transferase or 2-methyl-alkyl-succinyl-CoA synthetase that catalyzes the conversion of said 2-methyl-alkyl-succinate to a 2-methyl-alkyl-succinyl-CoA;c. an overexpressed 2-methyl-alkyl-malonyl-CoA mutase that catalyzes the isomerization of said 2-methyl-alkyl-succinyl-CoA to a 2-methyl-alkyl-malonyl-CoA; andd. an overexpressed 2-methyl-alkyl-malonyl-CoA decarboxylase that catalyzes the decarboxylation of said 2-methyl-alkyl-malonyl-CoA to an acyl-CoA.
  • 119. The microorganism of claim 117, wherein said enzymes catalyzing the sequence of reactions for the oxygen-independent activation and the conversion to the acyl-CoA and the generation of the product precursor acetyl-CoA and the acyl-CoA or the keto-acid comprise: a. an overexpressed alkyl succinate synthase that catalyzes the addition of fumarate to the alkane to produce a 2-methyl-alkyl-succinate;b. an overexpressed 2-methyl-alkyl-succinyl-CoA synthetase that catalyzes the conversion of said 2-methyl-alkyl-succinate to a 2-methyl-alkyl-succinyl-CoA;c. an overexpressed 2-methyl-alkyl-succinyl-CoA dehydrogenase that catalyzes the conversion of said 2-methyl-alkyl-succinyl-CoA to 2-methyl-alkyl-2-butenoyl-CoA;d. an overexpressed mesaconyl-C1-CoA-C4-CoA transferase that catalyzes the conversion of said 2-methyl-alkyl-2-butenoyl-CoA to 3-methyl-alkyl-2-butenoyl-CoA;e. an overexpressed mesaconyl-C4-CoA hydratase that catalyzes the conversion of said 3-methyl-alkyl-2-butenoyl-CoA to 3-methyl-alkyl-3-hydroxy-succinyl-CoA; andf. an overexpressed citramalyl-CoA lyase that catalyzes the conversion of said 3-methyl-alkyl-3-hydroxy-succinyl-CoA to acetyl-CoA and a keto-acid.
  • 120. The microorganism of claim 117, wherein said enzymes catalyzing the sequence of reactions for the oxygen-independent activation and the conversion to the acyl-CoA and the generation of product precursor acetyl-CoA and the acyl-CoA or keto-acid comprises: a. an overexpressed alkyl succinate synthase that catalyzes the addition of fumarate to the alkane to produce a 2-methyl-alkyl-succinate;b. an overexpressed succinyl-CoA:2-methyl-alkyl-succinyl-CoA transferase or 2-methyl-alkyl-succinyl-CoA synthetase that catalyzes the conversion of said 2-methyl-alkyl-succinate to a 2-methyl-alkyl-succinyl-CoA;c. an overexpressed 2-methyl-alkyl-succinyl-CoA dehydrogenase that catalyzes the conversion of said 2-methyl-alkyl-succinyl-CoA to 2-methyl-alkyl-2-butenoyl-CoA;d. an overexpressed mesaconyl-CoA hydratase/β-methylmalyl-CoA dehydratase that catalyzes the conversion of said 2-methyl-alkyl-2-butenoyl-CoA to 3-hydroxy-2-methyl-alkyl-succinyl-CoA;e. an overexpressed β-methylmalyl-CoA lyase that catalyzes the conversion of said 3-hydroxy-2-methyl-alkyl-succinyl-CoA to glyoxylate and an acyl-CoA;f. an overexpressed glyoxylate carboligase that catalyzes the conversion of said glyoxylate to tartronate semialdehyde;g. an overexpressed tartronate semialdehyde reductase that catalyzes the conversion of said tartronate semialdehyde to D-glycerate;h. an overexpressed glycerate kinase that catalyzes the conversion of said D-glycerate to 3-phospho-D-glycerate;i. glycolytic enzymes (phosphoglycerate mutase, enolase, pyruvate kinase) that catalyze the conversion of said 3-phospho-D-glycerate to pyruvate; andj. a pyruvate formate lyase or pyruvate dehydrogenase that catalyze the conversion of said pyruvate to acetyl-CoA.
  • 121. The microorganism of claim 117, wherein said enzymes catalyzing the sequence of reactions for the generation of the product precursor acetyl-CoA and the acyl-CoA or keto-acid comprises: a. an overexpressed acyl-CoA dehydrogenase that catalyzes the conversion of said acyl-CoA to a transenoyl-CoA;b. an overexpressed enoyl-CoA hydratase that catalyzes the hydration of said transenoyl-CoA to a 3-hydroxyacyl-CoA;c. an overexpressed 3-hydroxyacyl-CoA dehydrogenase that catalyzes the oxidation of said 3-hydroxyacyl-CoA to a β-ketoacyl-CoA; andd. an overexpressed thiolase that catalyzes the cleavage of an acetyl-CoA from said β-ketoacyl-CoA to produce acetyl-CoA and an acyl-CoA 2-carbons shorter than said starting acyl-CoA.
  • 122. The microorganism of claim 117, wherein said enzymes catalyzing the sequence of reactions for the regeneration of fumarate from the acyl-CoA or keto-acid comprises: a. an overexpressed propionyl-CoA carboxylase that catalyzes the carboxylation of propionyl-CoA to (S)-methyl-malonyl-CoA;b. an overexpressed methyl-malonyl-CoA epimerase that catalyzes the interconversion of said (S)-methyl-malonyl-CoA to (R)-methyl-malonyl-CoA;c. an overexpressed methyl-malonyl-CoA mutase that catalyzes the isomerization of said (R)-methyl-malonyl-CoA to succinyl-CoA; andd. an overexpressed succinyl-CoA:2-methyl-alkyl-succinyl-CoA transferase or succinyl-CoA synthetase that catalyzes the conversion of said succinyl-CoA to succinate.
  • 123. The microorganism of claim 117, wherein said pathway for the regeneration of fumarate from the acyl-CoA or keto-acid comprises: a. an overexpressed malate dehydrogenase for the conversion of said keto-acid (pyruvate) to malate; andb. an overexpressed fumarase for the dehydration of said malate to fumarate.
  • 124. The microorganism of claim 117, wherein said pathway for the regeneration of fumarate from the acyl-CoA or keto-acid comprises: a. an overexpressed carboxylic acid omega hydroxylase that catalyzes the conversion of said keto-acid to an omega-hydroxy-2-keto-acid;b. an overexpressed alcohol dehydrogenase that catalyzes the conversion of said omega-hydroxy-2-keto acid to an omega-oxo-2-keto-acid;c. an overexpressed aldehyde dehydrogenase that catalyzes the conversion of said omega-oxo-2-keto-acid to a dicarboxylic 2-keto-acid;d. an overexpressed ketoreductase or malate dehydrogenase that catalyzes the conversion of said dicarboxylic 2-keto-acid to malate; ande. an overexpressed fumarase for the dehydration of said malate to fumarate.
  • 125. The microorganism of claim 118, wherein said overexpressed alkyl succinate synthase is encoded by Azoarcus sp. H×N1 masBCDEG (A9J4K0, A9J4K2, A9J4K4, A9J4K6, A9J4J6), Desulfatibacillum alkenivorans assA1/assB1/assC1/assD1 (ACL03428.1, ACL03427.1, ACL03427.1, ACL03425.1), Desulfosarcina sp. BuS5 A39W_RS0101550/A39W_RS0101545/A39W_RS0101540/A39W_RS0101535/A39W_RS196 30/A39W_RS0101580 (WP_027352796.1, WP_027352795.1, WP_027352794.1, WP_027352793.1, WP_051374532.1, WP_027352800.1), Desulfatibacillum alkenivorans assA2/assB2/assC2/assD2 (ACL03892.1, ACL03893.1, ACL03891.1, ACL03895.1), Peptococcaceae sp. SCADC (WP_036747468.1), Aromatoleum sp. OcN1 masD (CBK27727.1), Desulfoglaeba alkanexedens assA (ADJ51097.1), or homologues.
  • 126. The microorganism of claim 117, wherein said enzymes catalyzing the sequence of reactions for the generation of the product precursor acetyl-CoA comprises: a. an overexpressed acyl-CoA dehydrogenase that catalyzes the conversion of said acyl-CoA to a transenoyl-CoA;b. an overexpressed enoyl-CoA hydratase that catalyzes the hydration of said transenoyl-CoA to a 3-hydroxyacyl-CoA;c. an overexpressed 3-hydroxyacyl-CoA dehydrogenase that catalyzes the oxidation of said 3-hydroxyacyl-CoA to a β-ketoacyl-CoA; andd. an overexpressed thiolase that catalyzes the cleavage of an acetyl-CoA from said β-ketoacyl-CoA to produce acetyl-CoA and an acyl-CoA 2-carbons shorter than said starting acyl-CoA.
  • 127. The microorganism of claim 117, wherein the sequence of reactions for the formation of a desired product from the acetyl-CoA intermediate is selected from a group comprising: a. a reverse beta oxidation (BOX-R) cycle comprised of:
  • 128. The microorganism of claim 117, wherein said termination pathway is selected from the group consisting of: a. a CoA cleaving thioesterase, an acyl-CoA:acetyl-CoA transferase, a phosphotransacylase and a carboxylate kinase, or an ACP cleaving thioesterase said product is selected from the group consisting of carboxylic acids, (3R)-β-hydroxy carboxylic acids, β-keto carboxylic acids, and α,β-unsaturated carboxylic acids;b. an alcohol-forming coenzyme-A thioester reductase, an aldehyde-forming CoA thioester reductase and an alcohol dehydrogenase, an alcohol-forming ACP thioester reductase, or an aldehyde-forming ACP thioester reductase and an alcohol dehydrogenase and said product is selected from the group consisting of primary alcohols, 1,(3R)-β diols, β-keto primary alcohols, and α,β-unsaturated primary alcohols;c. an aldehyde-forming CoA or ACP thioester reductase and an aldehyde decarbonylase and said product is selected from the group consisting of linear alkanes, linear alkan-2-ols, linear methyl-ketones, and 1-alkenes; andd. an aldehyde-forming CoA or ACP thioester reductase and a transaminase and said product is selected from the group consisting of primary amines, 3-hydroxy-amines, 3-keto-amines, and α,β-unsaturated primary amines.
  • 129. The microorganism of claim 119, wherein said overexpressed alkyl succinate synthase is encoded by Azoarcus sp. H×N1 masBCDEG (A9J4K0, A9J4K2, A9J4K4, A9J4K6, A9J4J6), Desulfatibacillum alkenivorans assA1/assB1/assC1/assD1 (ACL03428.1, ACL03427.1, ACL03427.1, ACL03425.1), Desulfosarcina sp. BuS5 A39W_RS0101550/A39W_RS0101545/A39W_RS0101540/A39W_RS0101535/A39W_RS 19630/A39W_RS0101580 (WP_027352796.1, WP_027352795.1, WP_027352794.1, WP_027352793.1, WP_051374532.1, WP_027352800.1), Desulfatibacillum alkenivorans assA2 assB2 assC2 assD2 (ACL03892.1, ACL03893.1, ACL03891.1, ACL03895.1), Peptococcaceae sp. SCADC (WP_036747468.1), Aromatoleum sp. OcN1 masD (CBK27727.1), Desulfoglaeba alkanexedens assA (ADJ51097.1), or homologues.
  • 130. The microorganism of claim 120, wherein said overexpressed alkyl succinate synthase is encoded by Azoarcus sp. H×N1 masBCDEG (A9J4K0, A9J4K2, A9J4K4, A9J4K6, A9J4J6), Desulfatibacillum alkenivorans assA1/assB1/assC1/assD1 (ACL03428.1, ACL03427.1, ACL03427.1, ACL03425.1), Desulfosarcina sp. BuS5 A39W_RS0101550/A39W_RS0101545/A39W_RS0101540/A39W_RS0101535/A39W_RS 19630/A39W_RS0101580 (WP_027352796.1, WP_027352795.1, WP_027352794.1, WP_027352793.1, WP_051374532.1, WP_027352800.1), Desulfatibacillum alkenivorans assA2/assB2/assC2/assD2 (ACL03892.1, ACL03893.1, ACL03891.1, ACL03895.1), Peptococcaceae sp. SCADC (WP_036747468.1), Aromatoleum sp. OcN1 masD (CBK27727.1), Desulfoglaeba alkanexedens assA (ADJ51097.1), or homologues.
PRIOR RELATED APPLICATIONS

This application is a divisional application of U.S. application Ser. No. 16/878,032, filed May 10, 2020, which is a continuation of U.S. application Ser. No. 15/562,606, filed Sep. 28, 2017, now abandoned, which is a 371 application of International Application No. PCT/US16/25103, published in English and filed on Mar. 31, 2016, which claims priority to U.S. Ser. No. 62/140,628, filed Mar. 31, 2015. The entire teachings of the above applications are incorporated herein by reference.

Provisional Applications (1)
Number Date Country
62140628 Mar 2015 US
Divisions (1)
Number Date Country
Parent 16878032 May 2020 US
Child 18413954 US
Continuations (1)
Number Date Country
Parent 15562606 Sep 2017 US
Child 16878032 US